Omics studies involve large-scale studies in genomics, proteomics, metabolomics and other "omes" to better understand the molecular infrastructure and dynamics of biological systems. Artificial intelligence (AI) has revolutionized omics studies by enabling insights from large and complex biological datasets. AI tools are allowing researchers to discover patterns, predict outcomes and develop new strategies for disease prevention and treatment.
The Global AI in Omics Studies Market is estimated to be valued at US$ 1118.17 Mn in 2024 and is expected to exhibit a CAGR of 35% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Global AI in Omics Studies are Thermo Fisher Scientific, Agilent Technologies, Illumina, BGI Genomics, Dassault Systèmes, Qiagen, Waters Corporation, GE Healthcare, Amazon Web Services, Inc., Bruker, Danaher. These companies are investing in developing AI-powered tools and platforms for genomics, proteomics and multi-omics analysis. The growing demand for personalized healthcare and precision medicine is driving increased adoption of AI in omics research. AI helps uncover meaningful insights from omics data to develop targeted therapies and diagnostics. Several pharmaceutical and biotech companies are partnering with AI players to accelerate drug discovery through multi-omics analysis.
Market Key Trends:
One of the key in AI In Omics Studies Market Size is increasing integration of AI and machine learning algorithms into omics workflows. AI tools are being embedded into laboratory instruments, sequencers, chromatography systems and other equipment used in genomic, proteomic and metabolomic analysis. This is allowing automated extraction of insights from omics data in a time-efficient manner. Another trend is the rising popularity of multi-omics analysis using integrated AI platforms. By analyzing patterns across multiple "omes", researchers are gaining a more holistic view of health and disease at the molecular level. This is poised to revolutionize systems biology research.
Porter’s Analysis
Threat of new entrants: low barriers to entry with advanced technologies and increased venture capital funding. Bargaining power of buyers: medium, as there are many established players in the market. Bargaining power of suppliers: medium as intellectual property right has significant value in this market. Threat of new substitutes: medium as new advanced technologies can disrupt the industry. Competitive rivalry: intense as many global players are competing by launching new advanced products to gain more market share
Geographical Regions
North America accounts for the largest share of the global AI in omics market owing to the presence of major healthcare IT companies and government funding for research activities in this region.The Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to increasing research collaborations between government and industrial players and rising R&D investment in molecular diagnostic techniques in major Asia Pacific countries like China and India.
Get more insights on: - AI In Omics Studies Market
For Enhanced Understanding, Dive into the Report in the Language that Connects with You:-
· French
· German
· Italian
· Russian
· Japanese
· Chinese
· Korean
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)